ARTICLE
|
doi:10.20944/preprints202209.0013.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
pediatric onset multiple sclerosis; POMS; highly effective treatments; disease modifying drugs; DMD
Online: 1 September 2022 (08:48:04 CEST)
CASE REPORT
|
doi:10.20944/preprints202404.0157.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
autoimmune encephalitis; checkpoint inhibitor; melanoma; pembrolizumab; adverse event
Online: 2 April 2024 (16:18:10 CEST)